C
Claudia Becker
Researcher at University of Basel
Publications - 5
Citations - 76
Claudia Becker is an academic researcher from University of Basel. The author has contributed to research in topics: Odds ratio & Relative risk. The author has an hindex of 4, co-authored 5 publications receiving 59 citations. Previous affiliations of Claudia Becker include University Hospital of Basel.
Papers
More filters
Journal ArticleDOI
Statin use and risk of glioma: population-based case-control analysis.
Corinna Seliger,Christoph R. Meier,Christoph R. Meier,Christoph R. Meier,Claudia Becker,Susan S. Jick,Ulrich Bogdahn,Peter Hau,Michael F. Leitzmann +8 more
TL;DR: Use of statins was not associated with risk of glioma, and previous sparse evidence of a possible inverse association between statin use andglioma risk was not supported.
Journal ArticleDOI
Diabetes, use of metformin, and the risk of meningioma.
Corinna Seliger,Christoph R. Meier,Claudia Becker,Susan S. Jick,Martin Proescholdt,Ulrich Bogdahn,Peter Hau,Michael F. Leitzmann +7 more
TL;DR: A matched case-control analysis using data from the U.K.-based Clinical Practice Research Datalink to analyse diabetes status, duration of diabetes, glycemic control, and use of metformin, sulfonylureas, and insulin in relation to the risk of meningioma found the suggestion of an inverse association.
Journal ArticleDOI
Metabolic syndrome in relation to risk of meningioma
Corinna Seliger,Christoph R. Meier,Claudia Becker,Susan S. Jick,Martin Proescholdt,Ulrich Bogdahn,Peter Hau,Michael F. Leitzmann +7 more
TL;DR: Obesity and arterial hypertension are positively associated with risk of meningioma and further studies are needed to better understand potential underlying biologic mechanisms.
Journal ArticleDOI
Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma
Corinna Seliger,Christoph R. Meier,Claudia Becker,Susan S. Jick,Ulrich Bogdahn,Peter Hau,Michael F. Leitzmann +6 more
TL;DR: Use of selective COX-2 inhibitors was unrelated to risk of glioma, and trends for increasing numbers of prescriptions for other non-steroidal anti-inflammatory drugs (NSAIDs), and non-NSAID analgesics were also not associated withglioma risk.
Journal ArticleDOI
Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma.
Tareq M. Anssar,Michael F. Leitzmann,Ralf A. Linker,Christoph R. Meier,Christoph R. Meier,Claudia Becker,Claudia Becker,Susan S. Jick,Katharina Sahm,Katharina Sahm,Michael Platten,Michael Platten,Peter Hau,Corinna Seliger,Corinna Seliger +14 more
TL;DR: It is hypothesized that autoimmune diseases associated with increased immune‐surveillance may also modulate the risk of human glioma, and data from the well‐validated Clinical Practice Research Datalink GOLD from the UK was used to test this hypothesis.